BioSpace News Archive

Drug Development

Esperion Announces Publication in the Journal of the American Medical Association of Bempedoic Acid Phase 3 Study 2 Results

Study 2 Demonstrated that Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced hsCRP

November 13, 2019
·
9 min read
Webinar on Weight-bearing CT with Dr. Robert Anderson 11-20-19

Dr. Robert Anderson will discuss new technology that improves patient care: weight-bearing computed tomography (CT). The CARESTREAM OnSight 3D Extremity System captures 3D cross-sectional images of bone or soft tissue in upper and lower extremities.

November 13, 2019
·
1 min read
Porvair expands range of capsule filters

Porvair Filtration Group is pleased to announce a further expansion to its range of microfiltration products by launching five new Microcap™ capsule filters in sizes suitable for small to medium industrial applications.

November 13, 2019
·
2 min read
Policy

HRA Pharma Receives ISO-13485 Certification

The ISO 13485 audit is an essential qualification for medical device manufacturers, showing HRA Pharma’s commitment to the highest quality standard.

November 13, 2019
·
2 min read
Policy

Promore Pharma is granted a patent for PXL01 in the US

Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, announced that its subsidiary Pergamum AB was granted a patent in the US for the pharmaceutical formulation of the product candidate PXL01.

November 13, 2019
·
3 min read
Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment

Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/ARP Annual Meeting

November 13, 2019
·
16 min read
Biotech Bay

Atara Biotherapeutics to present tab-cel® long-term clinical outcomes from a multicenter EAP study for patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) at the 61st ASH Annual Meeting

26 relapsed/refractory EBV+ PTLD patients were treated in a multicenter tab-cel® EAP study including a subgroup of 22 patients who would have likely met eligibility criteria for Atara’s ongoing tab‑cel® Phase 3 studies

November 13, 2019
·
11 min read
Deals

Merck Snaps Up Preclinical Neurodegenerative Asset in $576 Million Buy

Merck plunked down $576 million to acquire San Diego-based Calporta to gain access to preclinical TRPML1 agonists that are seen as potential treatments for neurodegenerative disorders such as Alzheimer’s or Parkinson’s.

November 13, 2019
·
2 min read
·
Alex Keown
Business

Amgen Exits Neuroscience R&D, Plans to Cut 149 Jobs in Boston Area

Unfortunately, this makes Amgen yet another major biopharma company to exit or slim down work on neurological diseases. Others include Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and AstraZeneca.

November 13, 2019
·
3 min read
·
Mark Terry
Regenstrief Institute and Indiana University School of Dentistry establish dental informatics program to improve oral health for better overall human health

With the goal of improving oral health for better overall physical and emotional health, Regenstrief Institute and Indiana University School of Dentistry are joining together to establish a novel dental informatics program.

November 13, 2019
·
7 min read